论文信息 - Psoriasis-Like Dermatitis Developing in an Atopic Dermatitis Patient Treated With Dupilumab.

Psoriasis-Like Dermatitis Developing in an Atopic Dermatitis Patient Treated With Dupilumab.

J.I.S. served as a consultant and/or advisory board member for Abbvie, AnaptysBio, Asana, Arena, Boehringer-Ingelheim, Dermavant, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Kiniksa, Leo, Menlo, Novartis, Pfizer, and Regeneron-Sanofi; is receiving honoraria from RealM; is speaker for Regeneron-Sanofi; and received research grants from GlaxoSmithKline. The other authors have no funding or conflicts of interest to declare. 376 DERMATITIS, Vol 43 • No 6 • November/December, 2019

J. Silverberg | Timothy L. Tan | M. Stout | J. Guitart

[1] G. Safa,et al. Psoriasis induced by dupilumab therapy , 2019, Clinical and experimental dermatology.

[2] Madonna Michael,et al. Erythrodermic presentation of psoriasis in a patient treated with dupilumab , 2018, JAAD case reports.

[3] U. Hauri,et al. Allergic contact dermatitis caused by a new temporary blue–black tattoo dye – sensitization to genipin from jagua (Genipa americana L.) fruit extract , 2017, Contact dermatitis.

[4] J. Waton,et al. A putative case of allergic contact dermatitis caused by a jagua tattoo , 2017, Contact dermatitis.

[5] R. Clark,et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. , 2013, The Journal of investigative dermatology.

[6] M. Sauvain,et al. Medical ethnobotany of the Chayahuita of the Paranapura basin (Peruvian Amazon). , 2013, Journal of ethnopharmacology.

[7] J. Ring,et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. , 2011, The New England journal of medicine.